Back to results
US 12,533,399 B2Granted
Composition comprising tTF-NGR for use in treating soft-tissue sarcoma
AssigneeAnturec Pharmaceuticals GmbH
InventorWolfgang E. Berdel
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions comprising Trabectedin or a tTF-NGR protein for use in the treatment of cancer in an individual, wherein the treatment comprises the following steps: (a) administering to the individual an effective amount of a composition comprising Trabectedin, and (b) subsequently administering to the individual an effective amount of a composition comprising a tTF-NGR protein.
Claims14
A method of treating cancer in an individual, wherein the treatment comprises the following steps:
- (a) administering to the individual an effective amount of a composition comprising Trabectedin, and
- (b) subsequently administering to the individual an effective amount of a composition comprising a tTF-NGR protein.
Dependencies are inferred from the claim text.